NFSG
TGTX icon

Newbridge Financial Services Group’s TG Therapeutics TGTX Stock Holding History

Newbridge Financial Services Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,700
Closed -$39.8K – 1180
2024
Q3 		$39.8K Sell
1,700
-1,384
-45% -$30.2K 0.01% 276
2024
Q2 		$54.9K Sell
3,084
-578
-16% -$9.22K 0.02% 360
2024
Q1 		$55.7K Sell
3,662
-1,150
-24% -$18.3K 0.02% 377
2023
Q4 		$82.2K Sell
4,812
-446
-8% -$5.18K 0.04% 306
2023
Q3 		$44K Buy
5,258
+1,312
+33% +$18.3K 0.02% 437
2023
Q2 		$98K Sell
3,946
-500
-11% -$12.9K 0.05% 318
2023
Q1 		$66.9K Buy
4,446
+174
+4% +$2.64K 0.04% 399
2022
Q4 		$50.5K Sell
4,272
-1,362
-24% -$9.88K 0.03% 459
2022
Q3 		$33K Buy
5,634
+962
+21% +$6.31K 0.02% 566
2022
Q2 		$20K Sell
4,672
-380
-8% -$2.37K 0.01% 664
2022
Q1 		$48K Hold
5,052
– – 0.02% 488
2021
Q4 		$96K Sell
5,052
-192
-4% -$4.99K 0.05% 318
2021
Q3 		$175K Sell
5,244
-378
-7% -$11.7K 0.11% 188
2021
Q2 		$218K Sell
5,622
-193
-3% -$7.58K 0.13% 167
2021
Q1 		$280K Buy
5,815
+5,306
+1,042% +$255K 0.21% 119
2020
Q4 		$26K Buy
+509
New +$17.2K 0.02% 478

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Newbridge Financial Services Group's TGTX Position: Q4 2024 in Review

Newbridge Financial Services Group sold out of TG Therapeutics (TGTX) in Q4 2024, closing a stake of 1,700 shares — an estimated $39.8K sold.

Newbridge Financial Services Group first reported a position in TGTX in Q4 2020 and held it in 16 quarters. The position peaked at $280K in Q1 2021. 331 funds tracked by Wall St. Rank hold TGTX as of Q4 2024.

  • Newbridge Financial Services Group reported no remaining TG Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 1,700 TG Therapeutics shares in Q4 2024, an estimated $39.8K.
  • Newbridge Financial Services Group first reported a position in TG Therapeutics in Q4 2020 and held it in 16 quarters.
  • Newbridge Financial Services Group's TG Therapeutics position peaked at $280K in Q1 2021.
  • 331 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2024.

Based on Newbridge Financial Services Group's 13F filing for Q4 2024, filed 28 Jan 2025.